Differentiated approach to treatment of severe acute pancreatitis based on organ failure pattern

Authors

DOI:

https://doi.org/10.30978/GS-2025-3-8

Keywords:

pancreatitis, multiple organ failure, acute necrotizing pancreatitis, treatment outcome, hospital length of stay, risk assessment, inflammation

Abstract

Severe acute pancreatitis (SAP) complicated by organ failure (OF) is associated with mortality rates of 15 – 40%. While the step‑up approach has proven superior to primary necrosectomy, its universal application fails to account for the heterogeneity of clinical trajectories. Early stratification of patients based on OF patterns may facilitate the development of personalised treatment protocols.

Objective – to evaluate the effectiveness of a differentiated treatment approach to severe acute pancreatitis based on organ failure patterns in comparison to standard disease management.

Materials and methods. A quasi‑experimental study with historical control was conducted in 77 patients with SAP or high risk of its development. The comparison group (n=41, 2014 – 2019) received standard treatment with retrospectively confirmed OF development. The main group (n=36, 2022 – 2024) underwent prospective stratification using a prognostic model within 24 hours of admission, identifying three OF patterns: early respiratory‑renal, late respiratory, and early multisystem. Pattern‑specific protocols were applied: aggressive early drainage for the early respiratory‑renal pattern, a maximal conservative approach for the late respiratory pattern, and intensive monitoring with readiness for emergency interventions for the early multisystem pattern. The primary endpoint was hospital length of stay (LOS). Secondary endpoints included OF development, intensive care unit (ICU) utilisation, surgical interventions, and mortality.

Results. Median hospital LOS decreased from 35 [23 – 65] to 27 [15 – 33.25] days (p=0.015), representing a 22.9% reduction. OF development was prevented in 33.3% of high‑risk patients (the number needed to treat is 3). The incidence of persistent OF decreased from 90.2% to 50.0% (odds ratio (OR)=0.11, 95% confidence interval (CI): 0.03 – 0.37, p<0.0001), and multiorgan failure from 31.7% to 5.6% (p=0.004). The treatment effect was pattern‑dependent (interaction p<0.0001): the late respiratory pattern showed a 44.4% LOS reduction (61.1±27.2 to 34.0±23.6 days, p=0.005), the early multisystem pattern demonstrated a 47.2% reduction (50.2±32.8 to 26.5±19.3 days, p=0.042), while the early respiratory‑renal pattern showed a non‑significant increase (+31.3%, p=0.870). The proportion of staged open operations decreased from 58.5% to 22.2% (p=0.001) without affecting emergency surgery rates. Mortality decreased from 12.2% to 8.3% (p=0.579).

Conclusions. Pattern‑oriented treatment of SAP significantly reduces hospitalisation duration and prevents OF development in one‑third of high‑risk patients. Treatment efficacy is heterogeneous across patterns, with the greatest benefit observed in late respiratory and early multisystem variants. This approach transforms the surgical paradigm from reactive to proactive, optimising intervention timing based on predicted clinical trajectory. Further multicentre validation is warranted to confirm these findings.

Author Biographies

H. O. Levytskyi, Poltava State Medical University

MD, PhD candidate, Department of Surgery No2

V. D. Sheiko, Poltava State Medical University

MD, PhD, DSc, Prof., Department of Surgery No2, 

References

Antcliffe DB, Burrell A, Boyle AJ, Gordon AC, McAuley DF, Silversides J. Sepsis subphenotypes, theragnostics and personalized sepsis care. Intensive Care Med. 2025;51(4):756-68. Epub 2025/03/31 21:16. http://doi.org/10.1007/s00134-025-07873-6. PubMed PMID: 40163135; PubMed Central PMCID: PMCPMC12055953.

Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-11. Epub 20121025. http://doi.org/10.1136/gutjnl-2012-302779. PubMed PMID: 23100216.

Besselink MG, van Santvoort HC, Nieuwenhuijs VB, Boermeester MA, Bollen TL, Buskens E, et al. Minimally invasive ‘step-up approach’ versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial [ISRCTN13975868]. BMC Surg. 2006;6:6. Epub 2006/04/12. http://doi.org/10.1186/1471-2482-6-6. PubMed PMID: 16606471; PubMed Central PMCID: PMCPMC1508161.

Boxhoorn L, van Dijk SM, van Grinsven J, Verdonk RC, Boermeester MA, Bollen TL, et al. Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis. N Engl J Med. 2021;385(15):1372-81. Epub 2021/10/07. http://doi.org/10.1056/NEJMoa2100826. PubMed PMID: 34614330.

Duan XP, Qin BD, Jiao XD, Liu K, Wang Z, Zang YS. New clinical trial design in precision medicine: discovery, development and direction. Signal Transduct Target Ther. 2024;9(1):57. Epub 2024/03/05. http://doi.org/10.1038/s41392-024-01760-0. PubMed PMID: 38438349; PubMed Central PMCID: PMCPMC10912713.

Fu CY, Yeh CN, Hsu JT, Jan YY, Hwang TL. Timing of mortality in severe acute pancreatitis: experience from 643 patients. World J Gastroenterol. 2007;13(13):1966-9. Epub 2007/04/28. http://doi.org/10.3748/wjg.v13.i13.1966. PubMed PMID: 17461498; PubMed Central PMCID: PMCPMC4146974.

Garami A, Hegyi P. Precision Medicine in Pancreatitis: The Future of Acute Pancreatitis Care. Function (Oxf). 2023;4(3):zqad015. Epub 2023/05/12. http://doi.org/10.1093/function/zqad015. PubMed PMID: 37168493; PubMed Central PMCID: PMCPMC10165548.

Hollemans RA, Bakker OJ, Boermeester MA, Bollen TL, Bosscha K, Bruno MJ, et al. Superiority of Step-up Approach vs Open Necrosectomy in Long-term Follow-up of Patients With Necrotizing Pancreatitis. Gastroenterology. 2019;156(4):1016-26. Epub 2018/11/06. http://doi.org/10.1053/j.gastro.2018.10.045. PubMed PMID: 30391468.

Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut. 2004;53(9):1340-4. Epub 2004/08/13. http://doi.org/10.1136/gut.2004.039883. PubMed PMID: 15306596; PubMed Central PMCID: PMCPMC1774183.

Kokosis G, Perez A, Pappas TN. Surgical management of necrotizing pancreatitis: an overview. World J Gastroenterol. 2014;20(43):16106-12. Epub 2014/12/05. http://doi.org/10.3748/wjg.v20.i43.16106. PubMed PMID: 25473162; PubMed Central PMCID: PMCPMC4239496.

Leppaniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27. Epub 2019/06/19. http://doi.org/10.1186/s13017-019-0247-0. PubMed PMID: 31210778; PubMed Central PMCID: PMCPMC6567462.

Levytskyi H, Sheiko V. The Use of Artificial Intelligence Models for Predicting the Dynamics of Acute Pancreatitis Progression. Ukrainian Medical Journal. 2024;163(5). http://doi.org/10.32471/umj.1680-3051.163.253646.

Li CL, Lin XC, Jiang M. Identifying novel acute pancreatitis sub-phenotypes using total serum calcium trajectories. BMC Gastroenterol. 2024;24(1):141. Epub 2024/04/24. http://doi.org/10.1186/s12876-024-03224-9. PubMed PMID: 38654213; PubMed Central PMCID: PMCPMC11036611.

Onnekink AM, Boxhoorn L, Timmerhuis HC, Bac ST, Besselink MG, Boermeester MA, et al. Endoscopic Versus Surgical Step-Up Approach for Infected Necrotizing Pancreatitis (ExTENSION): Long-term Follow-up of a Randomized Trial. Gastroenterology. 2022;163(3):712-22 e14. Epub 2022/05/18. http://doi.org/10.1053/j.gastro.2022.05.015. PubMed PMID: 35580661.

Petrov MS, Shanbhag S, Chakraborty M, Phillips AR, Windsor JA. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010;139(3):813-20. Epub 20100609. http://doi.org/10.1053/j.gastro.2010.06.010. PubMed PMID: 20540942.

Podda M, Pellino G, Di Saverio S, Coccolini F, Pacella D, Cioffi SPB, et al. Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study. Updates Surg. 2023;75(3):493-522. Epub 2023/03/11. http://doi.org/10.1007/s13304-023-01488-6. PubMed PMID: 36899292; PubMed Central PMCID: PMCPMC10005914.

Quinn J, Panasenko SI, Leshchenko Y, Gumeniuk K, Onderkova A, Stewart D, et al. Prehospital Lessons From the War in Ukraine: Damage Control Resuscitation and Surgery Experiences From Point of Injury to Role 2. Mil Med. 2024;189(1-2):17-29. Epub 2023/08/30. http://doi.org/10.1093/milmed/usad253. PubMed PMID: 37647607.

Reddy K, Sinha P, O’Kane CM, Gordon AC, Calfee CS, McAuley DF. Subphenotypes in critical care: translation into clinical practice. Lancet Respir Med. 2020;8(6):631-43. Epub 2020/06/12. http://doi.org/10.1016/S2213-2600(20)30124-7. PubMed PMID: 32526190.

Van Brunschot S, van Grinsven J, van Santvoort HC, Bakker OJ, Besselink MG, Boermeester MA, et al. Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial. Lancet. 2018;391(10115):51-8. Epub 20171103. http://doi.org/10.1016/S0140-6736(17)32404-2. PubMed PMID: 29108721.

Van Brunschot S, van Grinsven J, Voermans RP, Bakker OJ, Besselink MG, Boermeester MA, et al. Transluminal endoscopic step-up approach versus minimally invasive surgical step-up approach in patients with infected necrotising pancreatitis (TENSION trial): design and rationale of a randomised controlled multicenter trial [ISRCTN09186711]. BMC Gastroenterol. 2013;13:161. Epub 2013/11/28. http://doi.org/10.1186/1471-230X-13-161. PubMed PMID: 24274589; PubMed Central PMCID: PMCPMC4222267.

Van Santvoort HC, Besselink MG, Bakker OJ, Hofker HS, Boermeester MA, Dejong CH, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010;362(16):1491-502. http://doi.org/10.1056/NEJMoa0908821. PubMed PMID: 20410514.

Wang Z, Wang W, Xu J, He Q, Sun C, Xie S, et al. Development and validation of dynamic clinical subphenotypes in acute pancreatitis patients using vital sign trajectories in intensive care units: a multinational cohort study. Signal Transduct Target Ther. 2025;10(1):180. Epub 2025/06/05. http://doi.org/10.1038/s41392-025-02261-4. PubMed PMID: 40467599; PubMed Central PMCID: PMCPMC12137743.

Wilson JG, Calfee CS. ARDS Subphenotypes: Understanding a Heterogeneous Syndrome. Crit Care. 2020;24(1):102. Epub 2020/03/25. http://doi.org/10.1186/s13054-020-2778-x. PubMed PMID: 32204722; PubMed Central PMCID: PMCPMC7092435 worked as a consultant for Bayer, Roche/Genentech, CSL Behring, Prometic, and Quark. JGW receives grant funding from NIH.

Zhang C, Peng J, Wang L, Wang Y, Chen W, Sun MW, et al. A deep learning-powered diagnostic model for acute pancreatitis. BMC Med Imaging. 2024;24(1):154. Epub 2024/06/21. http://doi.org/10.1186/s12880-024-01339-9. PubMed PMID: 38902660; PubMed Central PMCID: PMCPMC11188273.

Downloads

Published

2025-10-30

How to Cite

1.
Levytskyi H, Sheiko V. Differentiated approach to treatment of severe acute pancreatitis based on organ failure pattern. ЗХ [Internet]. 2025Oct.30 [cited 2025Dec.4];(3):8-19. Available from: http://generalsurgery.com.ua/article/view/344468

Issue

Section

Original Research